Expectations, symptoms, and quality of life before and after 1 year of Pirfenidone treatment in patients with idiopathic pulmonary fibrosis: A single-arm, open-label nonrandomized study.
Dariusz JastrzebskiSabina Kostorz-NosalDagmara GalleAlicja Gałeczka-TurkiewiczJoanna WarzechaSebastian MajewskiWojciech Jerzy PiotrowskiDariusz ZioraPublished in: Health science reports (2023)
One year of antifibrotic treatment resulted in a general improvement in the quality of life per the SF-36 questionnaire. Patients' expectations of disease management did not change; also, access to novel therapies and easy access to health centers specializing in IPF management remained their top needs.